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ABSTRACT
‘Cell adhesion molecules’ (CAMs) are essential
elements of cell/cell communication that are impor-
tant for proper development and plasticity of a vari-
ety of organs and tissues. In the brain, appropriate
assembly and tuning of neuronal connections is
likely to require appropriate function of many cell
adhesion processes. Genetic studies have linked
and/or associated CAM variants with psychiatric,
neurologic, neoplastic, immunologic and develop-
mental phenotypes. However, despite increasing
recognition of their functional and pathological
significance, no systematic study has enumerated
CAMs or documented their global features. We
now report compilation of 496 human CAM genes
in six gene families based on manual curation of
protein domain structures, Gene Ontology annota-
tions, and 1487 NCBI Entrez annotations. We map
these genes onto a cell adhesion molecule ontology
that contains 850 terms, up to seven levels of depth
and provides a hierarchical description of these
molecules and their functions. We develop
OKCAM, a CAM knowledgebase that provides
ready access to these data and ontologic system
at http://okcam.cbi.pku.edu.cn. We identify global
CAM properties that include: (i) functional enrich-
ment, (ii) over-represented regulation modes and
expression patterns and (iii) relationships to human
Mendelian and complex diseases, and discuss the
strengths and limitations of these data.
INTRODUCTION
‘Cell adhesion molecules’ play central roles in much of
the connection and communication between cells and
their synapses (1). Cell adhesion-related communication
is essential for many aspects of the proper development
of a variety of organs and tissues (1). This cellular com-
munication also plays substantial roles in the plasticity of
cell recognition processes in the developed organism (2).
Cell adhesion molecules (CAM) may be especially
important in the brain. The brain requires proper connec-
tions of many trillions of synapses to develop properly
as well as substantial plasticity in many of these synapses
to facilitate learning and memory. The dynamics of neu-
ronal synaptic recognition, connection and disconnection
appear to make substantial contributions to disorders that
display mnemonic features, including addictions and
autism (3,4). Current physiologic and cell biologic studies
have implicated CAMs as good candidates to play impor-
tant roles in synapse adhesion (1,5), neuronal connectivity
and communication (1), signal transduction (5–8) and
proper arrangement of pre-synaptic active zones and post-
synaptic densities at classical synapses (9,10).
Current genetic studies have linked and/or associated
variants in cell adhesion molecule genes with psychiatric,
neurologic, neoplastic, immunologic and developmental
phenotypes. The importance of CAMs in learning and
memory-associated disorders is demonstrated in recent
genome wide association studies (11). Vulnerabilities to
addictions are associated with variants in CAM genes in
studies of several independent samples (12–14). Genetic
variants of the CAM genes NRXN1 and CNTNAP2
have been associated with autism (4,15). Variants in
neuregulin have been associated with vulnerability to
schizophrenia (16). Variants in an adhesion-like protein
KIAA0319 have been associated with dyslexia (17,18).
These data underscore the importance of cell adhesion
molecules in both Mendelian and complex disorders of
brain and other organs and suggest that a more compre-
hensive view of these genes and molecules would be valu-
able. However, there is currently no systematic study that
enumerates: (i) the number of genes and gene families that
function as CAMs; (ii) common and/or global CAM func-
tions, including those that might extend beyond their cell/
cell recognition functions; (iii) common CAM genetic
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structures and functions; (iv) over-represented regulation
modes and expression patterns and (v) CAM associations
with diseases, especially with brain disorders.
We now report compilation of a list of 496 human
CAM genes and construction of corresponding cell adhe-
sion molecule ontology (CAMO) to systematically address
these questions. Detailed annotations on CAM genes are
provided. Global properties of CAM genes, overrepre-
sented types of variation, overrepresented regulation
modes and expression patterns, and disease associations
are identiﬁed. We report a knowledgebase for cell adhe-
sion molecules (OKCAM) that provides ready access to
these data and the associated ontologic system that we
describe here.
IDENTIFICATION OF HUMAN CAM GENES
AND RODENT HOMOLOGS
CAMs were identiﬁed based on compilation of data from
manual curation of protein domain structures, Gene
Ontology annotations, and 1487 annotation entries from
keyword queries based on NCBI Entrez Gene annotations
(Figure 1). First, we identiﬁed features of common protein
domains for CAM families based on common motifs from
cadherin, immunoglobulin/FibronectinIII (IgFn), integ-
rin, neurexin, neuroligin and catenin families. Using
these features, we developed Perl scripts to retrieve and
standardize related InterPro domain architectures and the
proteins that contain such architectures (19). After manual
curation, 44 types of protein domains with 202 detailed
domain architectures were identiﬁed. These included 532
human proteins that map onto 218 human genes. We used
similar protocols to identify cell adhesion gene lists for rat
and mouse; these genes were then further mapped to the
human genome using Homologene (20). We next extracted
CAMs using the Gene Ontology term ‘cell adhesion’
(GO:0007155) (21). We focus on curated entries; entries
that are identiﬁed only by annotations that display
Evidence Code IEA (Inferred from Electronic
Annotation) are noted in Supplementary Table 7. Two
hundred eighteen human proteins were identiﬁed, which
mapped onto 196 human genes. Finally, we manually
curated 1487 annotation entries selected from results of
the Entrez Gene query ‘adhesion AND Homo sapiens
[organism]’ (20). This approach added 136 more human
genes to the list of cell adhesion molecules. In total, we
thus identiﬁed 496 unique human CAM genes and their
homologs in other species.
Meta-data about the domain architectures for CAMs in
nonhuman species provided information about CAM evo-
lutionary histories. Of the 113 types of protein domains
assessed in our dataset, 705 detailed domain architectures
were noted. Among these, only 44 domains with 202
domain architectures were identiﬁed in all of the three
species, human, rat and mouse. For example, in the cad-
herin superfamily, there is only one human gene encodes
a protein with enzymatic activity, though several dozen
cadherins with enzymatic activities are found in bacteria
and yeast. Several categories with large numbers of
domain architectures that can be detected in lower
species including Caenorhabditis elegans, Drosophila mela-
nogaster and Danio rerio, are totally absent from human,
rat and/or mouse. These categories include ‘IgCAM-
like cadherins’ that display 29 such domain architectures,
‘cadherins with Leucine-rich structures’ that display
two such domain architectures, ‘toxin-related cadherins’
that display such 36 domain architectures and ‘cadherins
with surface anchor structures’ that display seven such
domain architectures. In striking contrast, 119 of the 123
‘cadherin’ genes that can be identiﬁed in humans fall into
the category of ‘simple cadherins’, that includes genes with
only simple combinations of cadherin prodomains, cad-
herin domains and cadherin cytoplasmic domains.
Although 79%, not all, of the proteins that we identify
in this study display characteristic InterPro domains,
the domain architecture patterns we identify do imply
the speciﬁcation of the CAMs in mammals.
DATA ANNOTATIONS
To elucidate the functions of CAMs, detailed annotations
were given to each CAM gene. These data allow interpre-
tation of features of each CAM at ﬁve levels: gene family
and basic information, genetics, regulation, expression,
and Mendelian or complex disease linkage/association.
Information about gene family and basic characteriza-
tion comes from NCBI Entrez gene annotations (20),
Gene Ontology (21), InterPro domains (19), protein inter-
action databases (22–24), knowledgebases for molecular
pathways including KEGG (25), BioCarta and Pathway
Interaction Database (PID) and the NCBI PubMed data-
base (20). Genetic variations in these genes, including
chromosome recombination hotspots (26), SNPs (20),
insertion/deletions (27), chromosomal translocations (27)
and CNVs (27), were retrieved from the UCSC Genome
Browser Database (26), HapMap (28), NCBI dbSNP
database (20) and Database of Genomic Variants (27),
respectively. Information about potential or actual
modes of regulation was annotated based on the presence
of experimentally validated transcription factor binding
sites (TFBS) (29), experimentally validated (30,31) and
putative miRNA targets (32), noncoding RNA loci (33),
cis/trans-natural antisense transcripts (NATs) (34,35),
alternative splicing and post-translational modiﬁcations
(36) from databases that included TransFac (29),
Argonaute (31), TarBase (30), PicTar (32), NatsDB
(34,35), NONCODE (33) and dbPTM (36). Information
about mRNA expression levels came from: (i) integrated
human expressed sequence tag proﬁles based on develop-
mental stages and tissue distributions, as deposited in
Unigene (20) and (ii) mouse brain region expression
proﬁles described in the Allen Brain Atlas (37), with
mapping of these data to human orthologs using
Homologene (20). We integrated gene expression infor-
mation at peptide/protein levels by collecting expressed
proteins and peptides deposited in the PRIDE database
(38). To assess potential disease linkages or associations,
we integrated OMIM (20) and genome-wide association
datasets (39), from public data deposited in the Genetic
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genome wide association datasets.
Full descriptions of the annotation statistics are
provided in Table 1. These annotations, extending from
genome to post-translational modiﬁcation, provide a
novel avenue for studies of the global properties of
CAM genes, overrepresented types of variation, overre-
presented regulation modes and expression patterns, and
disease associations, as we discuss in the following
sections.
CONSTRUCTION OF A CAMO
We iteratively organized the information and knowledge
for CAMs to construct a novel CAMO. CAMO was con-
structed as a directed acyclic graph (DAG) using DAG-
Edit (40) to input, manage and update data, as shown in
the screenshot (Supplementary Figure 1). We annotated
each term with name, deﬁnition and source references. We
added its relationship to other terms based on manual
reviews of domain architecture and functional annotations
at the ﬁve levels noted above.
If vertices represent terms and the relationships between
terms are represented by edges, the terms in a DAG can be
connected via a directed graph without cycles. CAMO
thus provides a hierarchical description of functions and
properties of CAMs with ﬁve top-level categories: CAM
gene families, CAM genetics, CAM regulation, CAM
expression and CAM diseases. Each top-level term is
further divided into several categories to describe the func-
tions in detail (Figure 2). In toto, CAMO has 850 terms
with up to seven levels of depth. We mapped the 496
human genes that function in cell adhesion onto
CAMO, providing a novel systematic description of
CAMs (Figure 2). CAMO thus provides more speciﬁc,
complete and resolved information about CAMs to scien-
tists, especially to neuroscientists, than is available in
general-purposed ontologies such as MeSH (41) and
Gene Ontology (21).
OKCAM WEB INTERFACE DESIGN
We developed a PostgreSQL database termed ‘OKCAM
(Ontology-based Knowledgebase for Cell Adhesion
Molecules)’ to manage the CAM gene list, annotations
and ‘CAMO’. We implemented a web-based user interface
of this database that uses PHP and PHP/SQL query
scripts. Cross-references to key external databases were
included to integrate functional information about CAM
genes. These external databases provide annotations for
CAM gene families, CAM genetics and genomics, CAM
regulation modes and expression patterns, and relation-
ships between CAMs and human diseases (Figure 3).
The information for each CAM gene is integrated and
presented in a single graphical web page. For example,
the OKCAM entry page for cadherin 1 (CDH1) (http://
okcam.cbi.pku.edu.cn/entry-info.php?id=999) shows that
CDH1 is located on chromosome 16 in a chromosome
Figure 1. Collection of Human CAMs. CAMs were compiled by integrating Gene Ontology annotations, domain structure information and
keywords query against NCBI Entrez Gene annotations. Four hundred and ninety-six unique human genes were identiﬁed as CAMs (additional
genes that may also function in this way are identiﬁed in the supplement).
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number variations and insersion/deletions (‘CAM genet-
ics information’). CDH1 transcripts are relatively highly
expressed in adult (‘developmental stage’), mam-
mary gland (‘tissue distribution’) and cerebral cortex
(‘brain region’). Translation products are also expressed
in placenta/blood serum (‘protein expression’). CDH1
is implicated in neoplasia by genomewide association stu-
dies and OMIM annotations (‘CAM disease’). Potential
CDH1 regulatory modes include alternative splicing
regulation, cis-NATs regulation, miRNA regulation as
well as post-translational modiﬁcations (‘CAM regula-
tion’). Links to the original databases and other resources
facilitate information tracing.
We implemented four interactive browsing options in
OKCAM to facilitate user queries. Users can browse cell
adhesion genes by ‘CAMO’, displayed as hierarchical trees
on the homepage. They can zoom in on a particular
branch of the ontology by clicking the ‘+’ sign to
expand the branch. For example, a user interested in
‘psychiatric disorders’ may expand this category, focus
on ‘drug addiction’ and see the 49 CAM genes currently
mapped on this term by clicking the number that follows
this term (Figures 2 and 3). A ‘Chromosomal Overview’
browser supports browsing the CAM genes by clicks on
chromosomal locations marked by ‘+++’ (Figure 3).
A text search interface facilitates database queries that
use either gene IDs or names. A fourth interface supports
sequence searching based on BLAST nucleotide and
amino acid sequence similarities. Each interactive brows-
ing interface returns CAM gene/gene lists that meet query
requirements. Users can then obtain further detailed
annotation by clicking on the gene name (Figure 3).
A download page makes all data, database schema and
PostgreSQL commands available at http://okcam.cbi.
pku.edu.cn/download.php.
APPLICATIONS OF OKCAM
The comprehensive annotations and ontology system of
OKCAM facilitate studies of the global properties of
the CAM genes, overrepresented types of variation, over-
represented regulation modes and expression patterns,
and disease associations.
Table 1. Annotations for CAM genes
Description Evidence entry no. Annotated gene no. Annotation coverage (%) Reference
CAM gene families and basic information
NCBI Entrez Gene annotations 496 496 100.0 (20)
Pubmed entries 18371 490 98.8 (20)
Gene ontology annotations 4728 478 96.4 (21)
Protein interactions in BIND 230 77 15.5 (23)
Protein interactions in HPRD 2225 218 44.0 (24)
Protein interactions in BioGRID 2566 199 40.1 (22)
Enriched KEGG pathways 17 285 57.4 (25)
Enriched BioCarta pathways 19 259 52.2 NA
Enriched PID pathways (Pathway interaction database) 16 396 79.8 NA
CAM genetics
Recombination hotspots 714 252 50.8 (26)
Chromosome insertion/deletion 493 159 32.1 (27)
GVD CNV 371 150 30.2 (27)
SNP in CDS regions 3756 418 84.3 (20)
SNP in UTR regions 4489 429 85.5 (20)
SNP in Intron regions 236213 427 86.1 (20)
CAM expression
Unigene expression proﬁles 24480 451 90.9 (20)
Allen Brain Atlas expression Proﬁles (express in brain) 6205 355 71.6 (37)
Allen Brain Atlas expression Proﬁles (high expressed in brain) 1326 78 15.7 (37)
Proteomics evidence in PRIDE 15331 277 55.8 (38)
CAM regulation
Validated transcription factor binding sites in transfac 125 21 4.2 (29)
Validated transcription factor binding sites by chip-chip 189 140 28.2 (29)
Putative miRNA targets in PicTar 35513 236 47.6 (32)
Validated miRNA targets in TarBase 5 5 1.0 (30)
Validated miRNA targets in Argonaute 419 109 22.0 (31)
Cis-NATs regulation 221 219 44.2 (34,35)
Trans-NATs regulation 145 36 7.2 (34,35)
Noncoding RNA loci 167 95 19.2 (33)
Alternative splicing 11026 465 93.8 NA
Experiment validated PTMs 3080 373 75.2 (36)
Putative PTMs 15829 401 80.8 (36)
Possible CAM diseases and disorders
OMIM (with phenotype) 144 75 15.1 (20)
Vulnerable markers identiﬁed by GWA 647 80 16.1 (39)
In-house GWA vulnerable markers 121 64 12.9 NA
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CAMs in our dataset were annotated using Gene
Ontology (GO) (21) and the pathway databases KEGG
(25), BioCarta and Pathway Interaction Database (PID).
We can thus identify signiﬁcantly enriched Gene
Ontology terms and pathways using DAVID (42) and
KOBAS (43,44), respectively. We selected the functional
categories that were more likely to be biologically mean-
ingful by calculating the statistical signiﬁcance of each
functional category in the input set of genes versus all
annotated genes in the human genome. There was
statistically signiﬁcant enrichment for CAM genes in 16
Figure 2. Structure of CAMO. CAMO provides a hierarchical description of functions and properties of CAMs with ﬁve top-level categories
(A): CAM expression (B), CAM diseases (C), CAM genetics (D), CAM gene families (E) and CAM regulation (F). Each top-level term is further
divided into several categories that allow more detailed functional descriptions.
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‘subcellular localization’ terms (Supplementary Table 2)
and 45 ‘biological processes’ terms (Supplementary
Table 3), when compared to corresponding data for the
whole genome.
Identiﬁcation of functional enrichment for several of the
‘molecular function’ and ‘subcellular localization’ terms is
reassuring. This identiﬁcation provides relatively little
additional information, however, since CAMs do function
as ‘adhesion molecules’. Most are well documented to sit
within (or be anchored to) plasma membranes. However,
there is also signiﬁcant enrichment for other molecular
functions that might not have been so readily anticipated,
including calcium binding, protein kinase, and protein
phosphatase activities (Supplementary Tables 1 and 4).
The signiﬁcant overrepresentation of CAM localizations
within receptor complexes and extracellular matrix is also
of interest (Supplementary Table 2). It is interesting that
the CAMs identiﬁed in this work are overrepresented in
not only ‘cell adhesion’ but also in biological processes
that include signal transduction, responses to external
stimuli, cell motility, migration, and nervous system
development (Supplementary Table 3). Reassuringly,
the molecular pathway enrichment analyses that used
each of the three diﬀerent pathway databases provided
results that implicated their roles in largely similar func-
tional pathways (Supplementary Table 5).
Data from OKCAM annotations for protein interac-
tions allowed us to develop a molecular network based
on proteins that could interact with the CAMs identiﬁed
here (Supplementary Figure 2). As for other established
biological networks (45,46), the connectivity distribution
of the network that we nominated in this way appears to
follow scale-free rules. CAMs appear to interact with each
other to form a relatively tight ‘core’ that interrelates with
hundreds of other signal transduction genes. Focus on the
‘hub nodes’ in this apparent network (Supplementary
Figure 2) may even help to elucidate novel CAM roles
in signal transduction that come from its partnerships
with other signaling molecules.
CAM REGULATORY MODES
Mapping the CAMs in our dataset onto CAMO and
detailed gene structural/regulatory terms allows us to iden-
tify speciﬁc potential regulatory modes for these CAMs.
Figure 3. Structure of OKCAM Web Server. Several interactive browsing options were implemented to facilitate user queries of OKCAM. These
include ontology overview (A), full gene list overview (B), chromosomal overview (C), text search (D) and BLAST search (D). Each interactive
browsing interface returns CAM gene/gene lists that meet query requirements (F). Users can then obtain further detailed annotations mentioned
above by clicking on gene names (G). A download page makes all data, database schema and PostgreSQL commands available (E).
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these structural/regulatory modes are overrepresented
among CAMs. On human genomic level, both recombina-
tion ‘hotspots’ (Monte Carlo P=0.024) and copy number
variations (Monte Carlo P<0.0001) are over-represented
in chromosome regions that contain CAM genes. Indeed,
‘cell adhesion molecule’ is the GO category that is most
enriched in the genes that overlap with 1447 copy number
variants identiﬁed using Aﬀymetrix 500K and whole
genome TilePath (WGTP) reagents (47). There is a more
modest but still signiﬁcant 1.42-fold enrichment for
CAM genes in chromosomal regions that contain both
copy number variations and recombination hotspots
(P=0.07). By contrast, we detected no signiﬁcant diﬀer-
ence for the densities of single nucleotide polymorphisms
(SNP) distributions in chromosomal regions that contain
CAM genes versus the whole genome (P40.5).
When we tested potential overrepresentation of tran-
scriptional regulatory modes using hypergeometric tests,
we found that the potential for miRNA regulation
was signiﬁcantly enriched for CAM genes when compared
to the whole genome (P<0.0001). In contrast, no over-
represented transcription factor regulation for CAM genes
were detected using either low scale experimentally vali-
dated (P=0.37) or ChIP-chip data (P=0.51). There was
no signiﬁcant over- or under-representation of CAMs
among genes involved in either cis-o rtrans-NAT (35)
regulation (P40.5 for each).
We can also seek overrepresentation of CAM alterna-
tive splicing by compiling the alternative splicing isoforms
for each human gene mapped on CAMO and plotting the
distributions of the numbers of isoforms for (i) CAMs
versus (ii) all human genes (Supplementary Figure 3).
The overall distributions appear similar. However, genes
that utilize a wealth of alternative transcripts, those that
encode 40–50 alternatively spliced isoforms, are over-
represented in the dataset that encodes CAMs. These
genes provide an apparently distinct ‘peak’ in the distribu-
tion curve (Supplementary Figure 3). This analysis agrees
with our previous work that has characterized multiple
alternative splicing events in speciﬁc addiction-associated
CAMs (13).
We integrated post-translational modiﬁcation (PTM)
data to identify possible contributions of this regulatory
mode to CAM functions. On the basis of the experimen-
tally validated PTM data deposited in dbPTM, the 496
CAM genes are candidates for involvement in glycosyla-
tion (334 genes), phosphorylation (114 genes), amidation
(22 genes), palmitoylation (eight genes), methylation
(three genes), farnesylation (two genes), myristoylation
(two genes), sulfation (one gene) and acetylation (one
gene). There is a highly signiﬁcant enrichment for CAM
N-linked glycosylation (331 genes, P<0.0001), but not for
O-linked glycosylation (10 genes). No signiﬁcant over- or
under-representation was detected for other modes of post
translational modiﬁcation.
On the basis of the OKCAM annotations and CAMO,
we identiﬁed a list of regulatory modes for cell adhesion
molecules. These analyses identiﬁed both expected and
unexpected CAM regulatory modes. First, the data docu-
ment the overrepresentation of CNVs within CAM genes,
in ways that were suggested in even some of the initial
descriptions of CNVs (48). Documenting a 1.4-fold
enrichment for CAM genes in chromosomal regions that
contain both copy number variations and recombination
hotspots both supports these initial observations and pro-
vides a possible mechanism for the abundance of CNVs in
CAM genes. Secondly, although many papers have
described many alternative splicing isoforms for CAMs,
it was somewhat surprising to note that the largest diver-
sity of alternative transcripts (e.g. 40–50) was selectively
over-represented among CAM genes.
CAM EXPRESSION PATTERNS
Integration of data from human expressed sequence tags
(EST) derived from brain libraries and mouse brain
atlas expression proﬁles provided strong levels of agree-
ment that support use of this comparative approach
(Supplementary Table 6). We thus analyzed CAM expres-
sion patterns and levels in 17 mouse brain regions, based
on Allen Brain Atlas proﬁles from murine brains. For
each brain region, we used the program R to plot the
density curves that illustrate the frequency distributions
of expression levels for (i) CAMs and (ii) all human
genes expressed in this brain region (Supplementary
Figure 4). For 16 of the 17 brain regions, the expression
distribution curves for the two datasets merged. In these
brain regions, CAM genes taken as a group appear to be
expressed in ways that are not markedly diﬀerent from
those of other brain-expressed genes. However, in the
cerebral cortex, CAM genes with the highest expression
levels appear to be over-represented. There is thus an
additional peak in the CAM distribution curve that
is not found when all other genes are examined
(Supplementary Figure 4). While much prior data docu-
ments expression of many CAMs in cerebral cortex, the
speciﬁcity of the relatively richer expression of CAMs in
this brain region provides a novel observation.
CAM DISEASE ASSOCIATIONS
We assessed potential relationships between CAM var-
iants and disease using data from OMIM, public GWAS
data and our in-house datasets. These data nominate 167
human CAMs as likely to contain variants that could
contribute to individual diﬀerences in vulnerability to dis-
orders in brain and a variety of other organs (Figure 4).
CAMs were identiﬁed by association and/or linkage ﬁnd-
ings in disorders of the nervous system (91 genes), immune
system (30 genes), metabolism (29 genes), cardiovascular
system (28 genes), skin and connective tissues (26 genes),
musculoskeletal system (25 genes) and hyperplasia and/or
tumors (23 genes). When assessed in relation to speciﬁc
disorders or narrower classes of disorders, there were
relatively large numbers of cell adhesion molecules impli-
cated in substance dependence (49 genes), Alzheimer’s
disease (42 genes), tumors (21 genes), heart disease
(20 genes), bipolar disorder (18 genes), autoimmune dis-
eases (19 genes) and diabetes mellitus (17 genes). The
number of CAMs whose variants are tentatively
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anticipated by chance (Figure 4). The distribution of ﬁnd-
ings in other disorders is similar to that displayed by all
genes, when comparing data from either OMIM or GWA
datasets.
DISCUSSION
‘Cell adhesion molecules’ are increasingly recognized as
‘cell adhesion receptors’, since many of their functions
are just ‘cell glue’ but rather are more consistent with
roles in cell–cell and cell–matrix interactions and in
molecular recognition events that transduce signals. The
computational approaches that we use here to deﬁne
and characterize a universe of ‘cell adhesion’ molecules
provide both expected and unexpected results. These
results should be assessed in light of the strengths and
limitations of the approaches used here, and the strengths
and limitations of the underlying datasets employed for
these analyses. We also discuss details of the strengths
and limitations of these data in Supplementary Text 1.
We have attempted to provide as comprehensive a list
of human CAM genes, annotations and ontology-based
CAM knowledgebase as possible. However, it is clear
that there will be rapid progress in the study of
these molecules and of cell adhesion mechanisms. The
OKCAM database provides means for integrating new
data and updating knowledge, in ways that should
facilitate better and better understanding of the global
and speciﬁc CAM properties. As CAM genomic features
regulatory modes, expression patterns and disease associa-
tions become clearer, we thus hope that OKCAM should
become even more comprehensive and useful.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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